Richard Morgan

Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.

Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom.

EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom.

Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The company is based in Kirkland, Canada.

Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers.

Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013.

Synpromics Agbiosub Ltd. is a British company that engages in research and experimental development on biotechnology. The private company is based in London, UK.

ACM Biolabs Pte Ltd. operates as a synthetic biology company which uses its ACM technology platform to allow clients to develop diagnostics, therapeutics and vaccines targeting novel membrane proteins. The company was founded by Madhavan Nallani in 2013 and is headquartered in Singapore.

Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers.

Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York.

i3 Global operates as a pharmaceutical services company. It offers therapeutically specialized contract research solutions, clinical data services, staffing solutions, pharmacovigilance and epidemiology solutions. The company was founded in 1988 and is headquartered in Bernards, NJ.

SYN thesis med chem Pty Ltd. engages in the development and provision of molecule drug discovery services. It offers integrated drug discovery, medicinal and synthetic chemistry, single compound synthesis, and catalogue products. The company was founded by Andrew Wilks and Xian Bu and is headquartered in Parkville, Australia.

Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014.

QSpine Ltd. designs, manufactures and distributes medical devices in the surgical spine market segment. Its products include Mobi-C, sterispine pedicle screw, sterispine lumber cage and spinetune and shivas cervical cage. The company was founded by Forbes Butterfield and Stuart Hunter Carmichael in 2011 and is headquartered in Corby, the United Kingdom.

Vascular Flow Technologies Ltd. develops vascular devices. It offers Spiral Flow Peripheral Vascular Graft, Spiral Flow AV Access Graft, Spiral Laminar Flow, Power of Spiral Laminar Flow and unique design eliminates graft turbulences. The company was founded by Peter Stonebridge, Brian Howlett, Graeme Houston and John B.C. Dick and headquartered in Dundee, the United Kingdom.

Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA.

Farmaprojects SA provides regulatory affairs services to third party companies. The company was founded in 1988 and is headquartered in Barcelona, Spain.

ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom.

Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria.

Ambicare Health Ltd. manufactures medical products for skin care. The firm develops and commercializes proprietary, light emitting diode (LED) based devices for the treatment skin conditions and diseases. Its ambulatory lighting products offer solutions incorporating OLED (Organic Light Emitting Diode) and LED (Light Emitting Diode) technologies. The products offer battery operated flexible packaged solutions with high light uniformity. The company was founded by James Ferguson and Ifor Samuel in 2004 and is headquartered in Livingston, the United Kingdom.

Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia.

Founded in 1929, Glaxo Laboratories Ltd. is a pharmaceutical wholesaler that is part of GSK Plc. The company is based in London, UK.

Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom.

Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. develops ocular therapeutics and treatments for rare diseases. The private company is based in Beijing, CN. and has subsidiaries in the United States. The CEO of the Chinese company is Darren Mercer.